Evidence map›Paper›PMID 28916716›Full record

ArticleAnnals of the rheumatic diseases2018

Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.

Shu-Fang Wang-Renault, Saida Boudaoud, Gaétane Nocturne, Elodie Roche, Nelly Sigrist, Christian Daviaud, Andreas Bugge Tinggaard, Victor Renault, Jean-François Deleuze, Xavier Mariette and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 3 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Manifestations and management of Sjögren's disease.Arthritis research & therapy · 2024
    Review
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Shu-Fang Wang-RenaultLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Saida BoudaoudAP-HP, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Paris, France.
Gaétane NocturneAP-HP, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Paris, France.
Elodie RocheLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Nelly SigristLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Christian DaviaudLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Andreas Bugge TinggaardLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Victor RenaultFondation Jean Dausset - CEPH, Laboratory for Bioinformatics, Paris, France.
Jean-François DeleuzeLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Xavier MarietteAP-HP, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Paris, France.
Jörg TostLaboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine - CEA - Institut de Biologie Francois Jacob, Evry, France.
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRDirection de la Recherche Fondamentale · FRAarhus University · DKAssistance Publique – Hôpitaux de Paris · FRCentre National de Recherche en Génomique Humaine · FRFondation Jean Dausset-CEPH · FRHôpitaux Universitaires Paris-Ouest · FRInfectious Disease Models and Innovative Therapies · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMicroRNAs (miRNAs) play an important role in the pathogenesis of autoimmune diseases such as primary Sjögren's syndrome (pSS). This study is the first to investigate miRNA expression patterns in purified T and B lymphocytes from patients with pSS using a high-throughput quantitative PCR (qPCR) approach.

methodsTwo independent cohorts of both patients with pSS and controls, one for discovery and one for replication, were included in this study. CD4+ T cells and CD19+ B cells were isolated from peripheral blood mononuclear cells by magnetic microbeads and expression of miRNAs was profiled using the Exiqon Human miRNome panel I analysing 372 miRNAs. A selection of differentially expressed miRNAs was replicated in the second cohort using specific qPCR assays.

resultsA major difference in miRNA expression patterns was observed between the lymphocyte populations from patients with pSS and controls. In CD4 T lymphocytes, hsa-let-7d-3p, hsa-miR-155-5 p, hsa-miR-222-3 p, hsa-miR-30c-5p, hsa-miR-146a-5p, hsa-miR-378a-3p and hsa-miR-28-5 p were significantly differentially expressed in both the discovery and the replication cohort. In B lymphocytes, hsa-miR-378a-3p, hsa-miR-222-3 p, hsa-miR-26a-5p, hsa-miR-30b-5p and hsa-miR-19b-3p were significantly differentially expressed. Potential target mRNAs were enriched in disease relevant pathways. Expression of B-cell activating factor (

conclusionsThis study demonstrates major miRNAs deregulation in T and B cells from patients with pSS in two independent cohorts, which might target genes known to be involved in the pathogenesis of pSS.

Indexed as

Gene Expression RegulationAgedB-Cell Activating FactorB-LymphocytesCase-Control StudiesCD4-Positive T-LymphocytesCohort StudiesFemaleHumansLeukocytes, MononuclearMaleMicroRNAsMiddle AgedReal-Time Polymerase Chain ReactionSjogren's SyndromeB-Cell Activating FactorMicroRNAsCD19+ B lymphocytesCD4+ T lymphocytesepigeneticsmicroRNAsSjögren’s syndrome

Identifiers

PMID28916716
PMCPMC5754740
OpenAlexW2756090084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.